(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 3.72% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.88%.
Revvity's revenue in 2026 is $2,902,407,000.On average, 21 Wall Street analysts forecast RVTY's revenue for 2026 to be $325,196,738,295, with the lowest RVTY revenue forecast at $308,574,332,118, and the highest RVTY revenue forecast at $347,954,931,987. On average, 21 Wall Street analysts forecast RVTY's revenue for 2027 to be $341,930,704,245, with the lowest RVTY revenue forecast at $319,841,869,191, and the highest RVTY revenue forecast at $367,031,653,170.
In 2028, RVTY is forecast to generate $362,011,463,385 in revenue, with the lowest revenue forecast at $336,687,394,914 and the highest revenue forecast at $388,116,450,267.